ReviewEchocardiography (Mount Kisco, N.Y.)2026
Beyond E/e': A Physiology-Based Framework for Emerging Echocardiographic Biomarkers in the Noninvasive Assessment of Left Ventricular Filling Pressure.
Review in Echocardiography (Mount Kisco, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAccurate noninvasive estimation of left ventricular (LV) filling pressure is essential for diagnosing and managing heart failure and other cardiovascular diseases. Although the E/e' ratio remains the cornerstone of contemporary echocardiographic assessment, its diagnostic performance is influenced by loading conditions, myocardial disease, cardiac rhythm, and technical limitations. This review presents a physiology-based framework for emerging echocardiographic biomarkers, examining how each parameter reflects distinct pathophysiological processes-including myocardial relaxation, myocardial performance, atrial remodeling, and structural remodeling-and how these processes contribute to the estimation of LV filling pressure.
methodsA structured narrative review of the contemporary literature was performed, emphasizing studies evaluating both conventional and emerging echocardiographic parameters against invasive hemodynamic reference standards. Biomarkers were classified according to the physiological processes they primarily represent rather than being reviewed as isolated imaging parameters. Particular attention was given to their mechanistic rationale, diagnostic performance, clinical applicability, technical limitations, and potential integration into multiparametric assessment strategies.
resultsEmerging echocardiographic biomarkers provide complementary physiological information beyond conventional Doppler indices. Left atrial reservoir strain and left atrial stiffness primarily reflect chronic pressure elevation and atrial remodeling, whereas diastolic strain rate and left ventricular untwisting characterize impaired myocardial relaxation. Global longitudinal strain and myocardial work predominantly assess myocardial performance, while three-dimensional echocardiography improves structural characterization. Artificial intelligence functions as an integrative analytical approach capable of combining multidimensional imaging and clinical data rather than representing an independent physiological biomarker. Current evidence indicates that no single parameter adequately captures the complex determinants of LV filling pressure. Instead, each biomarker contributes distinct physiological information with varying diagnostic value depending on the underlying disease phenotype and clinical context.
conclusionsAssessment of LV filling pressure should move beyond the search for a single superior biomarker toward physiology-guided integration of complementary echocardiographic parameters. Future advances should emphasize standardized acquisition protocols, prospective multicenter validation against invasive hemodynamic reference standards, improved reproducibility, and clinically interpretable artificial intelligence-assisted models. Such an integrated physiology-based approach may enhance diagnostic accuracy, refine phenotypic characterization, and facilitate more individualized cardiovascular care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.